2 electronic medical records stocks

Digitizing health care data is revolutionizing the industry, and these companies are top plays on this trend.

By TheStockAdvisors Jul 2, 2012 10:17AM
By Andy Obermueller, Game-Changing Stocks

The reasoning behind converting to electronic medical records is simple: efficiency. Digital records will help end medical errors, stop unnecessary tests and eliminate the danger of improper drug interaction -- all while streamlining workloads, decreasing paperwork and lowering costs.

Computerized records can revolutionize the industry, just as they did for banking and retail. And Athenahealth (ATHN) and Allscripts (MDRX) are my favorite software plays on this market.

When the American Recovery and Reinvestment Act -- known as the Stimulus Act -- was signed in 2009, it incorporated the HITECH Act and federal "meaningful use" incentive program for digital medical records.

HITECH provides some $35 billion in subsidies to physicians and hospitals that prove they have adopted and are using EHR technology. But most of these health care providers have yet to begin the process.

So how much will our nation's health care system be spending to convert to a completely digitized system?

At an average cost to hospitals of $100,000 per licensed bed for electronic health records (EHR) software, the total price tag for the conversion to these systems has been estimated at nearly $100 billion.

Estimates for doctors' offices vary, but a sampling of the forecasts I found started at $25,000 per physician. There are nearly 700,000 doctors in the United States, which conceivably adds another $17.5 billion.

This won't be a one-time deal, either. The digitization of our medical records will require future software updates and upgrades. As our health care system finally enters the age of the Internet, there will continue to be opportunities for EHR companies to innovate the space.

Right now, both Athenahealth and Allscripts should see increased revenue as more hospitals make the switch to their EHR software.

Athenahealth is already showing signs of increased revenue from the spending. In 2011, it brought in $324.5 million, up from $245.5 million in 2010 -- a 32% gain. The company serves nearly 33,000 medical providers, including more than 23,200 physicians.

My other favorite, Allscripts, at last count, sells its products to over 180,000 physicians, 1,500 hospitals and 10,000 post-acute organizations, which help patients transition from long-term hospital care back to the community.

Its marketing is methodical: One practice at a time, one system at a time, one region at a time. Once it gains a customer, it seeks to sell to everyone that provider works with, then, every provider that all of those caregivers work with, until the entire region is using the same seamless Allscripts system.

So far the company's method seems to be working as Allscripts was able to double its revenue to $1.4 billion in 2011, compared to a year earlier.

Of course, with investing, nothing is 100% certain. These are both smaller companies, so you can expect above average volatility if the market suffers a setback.

But one thing is for certain -- the new medical EHR software is going to be big. And with 80% of U.S. hospitals still yet to implement the program, both Allscripts and Athenahealth could be clear beneficiaries.

More from TheStockAdvisors


Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

125 rated 1
264 rated 2
485 rated 3
679 rated 4
640 rated 5
617 rated 6
632 rated 7
493 rated 8
276 rated 9
153 rated 10

Top Picks

TAT&T Inc9



Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.